MCM2 and cancer: Our findings showed that the MCM2 expression was negatively correlated with immune infiltration in 15 cancer species (p < 0.01), such as GBM, UCEC, BRCA, LUAD, HNSC, LUSC, THYM, LIHC, OV, etc. (Fig. 6A, Supplementary Table5).